Terms: = Brain cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Staging
326 results:
1. Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancer.
Wegen S; Claus K; Linde P; Rosenbrock J; Trommer M; Zander T; Tuchscherer A; Bruns C; Schlößer HA; Schröder W; Eich ML; Fischer T; Schomäcker K; Drzezga A; Kobe C; Sabine Roth K; Weindler JJ
Radiat Oncol; 2024 Apr; 19(1):44. PubMed ID: 38575990
[TBL] [Abstract] [Full Text] [Related]
2. Pineal anlage tumor: clinical and diagnostic features, and rationales for treatment.
Obrecht-Sturm D; Pfaff E; Mynarek M; Bison B; Rodehüser M; Becker M; Kietz S; Pfister SM; Jones DT; Sturm D; von Deimling A; Sahm F; Kortmann RD; Schwarz R; Pietsch T; Fleischhack G; Rutkowski S
J Neurooncol; 2024 Jan; 166(2):359-368. PubMed ID: 38253790
[TBL] [Abstract] [Full Text] [Related]
3. Diagnostic value of [ 68 Ga]Ga-Pentixafor PET/CT in malignant melanoma: a pilot study.
Manafi-Farid R; Mahini M; Mirshahvalad SA; Fallahi B; Fard-Esfahani A; Emami-Ardekani A; Eftekhari M; Mousavi SA; Beiki D
Nucl Med Commun; 2024 Mar; 45(3):221-228. PubMed ID: 38214076
[TBL] [Abstract] [Full Text] [Related]
4. Dabrafenib plus trametinib in unselected advanced BRAF V600-mut melanoma: a non-interventional, multicenter, prospective trial.
Richtig E; Nguyen VA; Koelblinger P; Wolf I; Kehrer H; Saxinger W; Ressler JM; Weinlich G; Meyersburg D; Hafner C; Jecel-Grill E; Kofler J; Lange-Asschenfeldt B; Weihsengruber F; Rappersberger K; Svastics N; Gasser K; Seeber A; Kratochvill F; Nagler S; Mraz B; Hoeller C
Melanoma Res; 2024 Apr; 34(2):142-151. PubMed ID: 38092013
[TBL] [Abstract] [Full Text] [Related]
5. PATIENT-RELATED FACTORS AND CLINICAL MANAGEMENT OUTCOMES OF RETINOBLASTOMA IN CALABAR, NIGERIA.
Nkanga ED; Nlemadim AC; Arazi M; Nkanga DG; Duke RE; Fabian ID; Nkanga ED; Odey FA; Meremikwu MM
West Afr J Med; 2023 Dec; 40(12 Suppl 1):S36-S37. PubMed ID: 38070170
[TBL] [Abstract] [Full Text] [Related]
6. Overall survival and associated factors in women with metastatic breast cancer treated with trastuzumab at a public referral institution.
Gonçalves DS; Santos AMRD; Costa SCVD; Costa RSD; Senna KMSE; Zimmermann IR
Rev Bras Epidemiol; 2023; 26():e230045. PubMed ID: 37878833
[TBL] [Abstract] [Full Text] [Related]
7. Pineal/germ cell tumors and pineal parenchymal tumors.
Ogiwara H; Liao YM; Wong TT
Childs Nerv Syst; 2023 Oct; 39(10):2649-2665. PubMed ID: 37831207
[TBL] [Abstract] [Full Text] [Related]
8. Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
Wang J; Huang J; Ding H; Ma J; Zhong H; Wang F; Chen Y; Peng H
BMC Cancer; 2023 Oct; 23(1):929. PubMed ID: 37784026
[TBL] [Abstract] [Full Text] [Related]
9. Diagnostic value of 18 F-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in acral melanoma-predominant Asian patients.
Chen KC; Chu PY; Li CY; Wang TH; Chiu YJ
J Chin Med Assoc; 2023 Nov; 86(11):975-980. PubMed ID: 37738518
[TBL] [Abstract] [Full Text] [Related]
10. Epidemiology and survival outcomes of synchronous and metachronous brain metastases: a retrospective population-based study.
Jiang K; Parker M; Materi J; Azad TD; Kamson DO; Kleinberg L; Ye X; Rincon-Torroella J; Bettegowda C
Neurosurg Focus; 2023 Aug; 55(2):E3. PubMed ID: 37527669
[TBL] [Abstract] [Full Text] [Related]
11. [WHO Histological Classification of Pituitary Tumors].
Nishioka H
No Shinkei Geka; 2023 Jul; 51(4):642-653. PubMed ID: 37491061
[TBL] [Abstract] [Full Text] [Related]
12. Treatment outcome of patients with synchronous oligometastatic non-small cell lung cancer in the immunotherapy era: Analysis of a real-life intention-to-treat population.
Jongbloed M; Bartolomeo V; Steens M; Dursun S; van de Lisdonk T; De Ruysscher DKM; Hendriks LEL
Eur J Cancer; 2023 Sep; 190():112947. PubMed ID: 37451182
[TBL] [Abstract] [Full Text] [Related]
13. Efficacy of stereotactic radiation therapy for the treatment of confirmed or presumed canine glioma.
Trageser E; Martin T; Burdekin B; Hart C; Leary D; LaRue S; Boss MK
Vet Comp Oncol; 2023 Dec; 21(4):578-586. PubMed ID: 37423611
[TBL] [Abstract] [Full Text] [Related]
14. Genomic Alterations and the Incidence of brain Metastases in Advanced and Metastatic NSCLC: A Systematic Review and Meta-Analysis.
Gillespie CS; Mustafa MA; Richardson GE; Alam AM; Lee KS; Hughes DM; Escriu C; Zakaria R
J Thorac Oncol; 2023 Dec; 18(12):1703-1713. PubMed ID: 37392903
[TBL] [Abstract] [Full Text] [Related]
15. [A Case of Multiple brain Metastases after Surgery for Lung cancer Successfully Treated with Osimertinib].
Takeuchi K; Hayakawa N; Ouchi M
Gan To Kagaku Ryoho; 2023 May; 50(5):631-633. PubMed ID: 37218327
[TBL] [Abstract] [Full Text] [Related]
16. Head-to-Head Comparison of [
Ballal S; Yadav MP; Roesch F; Raju S; Satapathy S; Sheokand P; Moon ES; Martin M; Awarwal S; Tripathi M; Bal C
Thyroid; 2023 Aug; 33(8):974-982. PubMed ID: 37171126
[No Abstract] [Full Text] [Related]
17. Evaluation of 11 C-Choline PET/CT for T staging and Tumor Volume Delineation in Nasopharyngeal cancer Patients in Comparison to 18 F-FDG PET/CT.
Li C; Yang Y; Hu F; Xu Y; Wu B; Huang J; Yang K; Lan X
Clin Nucl Med; 2023 Jul; 48(7):563-573. PubMed ID: 37115936
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic assessment in patients operated for brain metastasis from systemic tumors.
Grossenbacher B; Lareida A; Moors S; Roth P; Kulcsar Z; Regli L; Le Rhun E; Weller M; Wolpert F
Cancer Med; 2023 Jun; 12(11):12316-12324. PubMed ID: 37039262
[TBL] [Abstract] [Full Text] [Related]
19. brain imaging in lung cancer staging: A real-world, multi-centre study of prevalence of brain metastases, impact on treatment and re-modelling of the NICE health economic analysis.
Brockelsby C; Maconachie R; Navani N; Prendecki R; Randles V; King J; Dildar B; Lee X; Nagarajan T; Rice M; Al-Najjar H; Atkins A; Sundar R; Brown L; Sharma S; O'Dowd E; Crisp E; Tufail M; Vella C; Grundy S; Evison M
Lung Cancer; 2023 Apr; 178():145-150. PubMed ID: 36858004
[TBL] [Abstract] [Full Text] [Related]
20. Radiographic predictors of occult intracranial involvement in olfactory neuroblastoma patients.
Geltzeiler M; Choby GW; Ji KSY; JessMace C; Almeida JP; de Almeida J; Champagne PO; Chan E; Ciporen JN; Chaskes MB; Cornell S; Drozdowski V; Fernandez-Miranda J; Gardner PA; Hwang PH; Kalyvas A; Kong KA; McMillan RA; Nayak JV; Patel C; Patel ZM; Celda MP; Pinheiro-Neto C; Sanusi OR; Snyderman CH; Thorp BD; Van Gompel JJ; Zadeh G; Zenonos G; Zwagerman NT; Wang EW
Int Forum Allergy Rhinol; 2023 Oct; 13(10):1876-1888. PubMed ID: 36841933
[TBL] [Abstract] [Full Text] [Related]
[Next]
